Robert Langer receives Kyoto Prize
Institute Professor cited as "a founder of the field of tissue engineering."
Institute Professor cited as "a founder of the field of tissue engineering."
Engineering tiny paths to cancer treatment, bone regrowth, and wound healing, Paula Hammond serves as an exemplary researcher-educator within the MIT community.
RNA carried by new nanoparticles can silence genes in many organs, could be deployed to treat cancer.
Nanoparticles that stagger delivery of two drugs knock out aggressive tumors in mice.
Test analyzing cells’ ability to fix different kinds of broken DNA could help doctors predict cancer risk.
Killian Award recipient Stephen Lippard describes his work on platinum-based chemotherapy agents.
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Study reveals immune cells that are critical to combating the parasite in early stages of infection.
MIT is one of six institutions receiving a total of $540 million to provide reliable, long-term support for high-impact, innovative research.
Studying these cells could lead to new treatments for diseases ranging from gastrointestinal disease to diabetes.
Drugs that block new target gene could make many tumors more vulnerable to chemotherapy.